[artículo]
| Título : |
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group |
| Tipo de documento: |
texto impreso |
| Autores: |
Hans Jürgen Möller, Autor ; Hans Peter Volz, Autor ; Ingrid W. Reimann, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 59-65 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Alprazolam, Ansiolíticos, Antidepresivos, Trastornos de ansiedad, Opipramol. |
| Resumen: |
Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has pronounced D2-, 5-HT2-, and H1-blocking potential and high affinity to sigma receptors (sigma-1 and sigma-2). In early controlled trials, anxiolytic effects were revealed. However, those studies were performed before the concept of generalized anxiety disorder (GAD) was established. |
| Link: |
./index.php?lvl=notice_display&id=31138 |
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 59-65
[artículo] Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group [texto impreso] / Hans Jürgen Möller, Autor ; Hans Peter Volz, Autor ; Ingrid W. Reimann, Autor . - 2023 . - pp. 59-65. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 59-65
| Palabras clave: |
Alprazolam, Ansiolíticos, Antidepresivos, Trastornos de ansiedad, Opipramol. |
| Resumen: |
Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has pronounced D2-, 5-HT2-, and H1-blocking potential and high affinity to sigma receptors (sigma-1 and sigma-2). In early controlled trials, anxiolytic effects were revealed. However, those studies were performed before the concept of generalized anxiety disorder (GAD) was established. |
| Link: |
./index.php?lvl=notice_display&id=31138 |
|
Refinar búsquedaOpipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)
